ATE396992T1 - Salze eines chinuclidin-derivats als antagonisten des muscarin-m3-rezeptors - Google Patents

Salze eines chinuclidin-derivats als antagonisten des muscarin-m3-rezeptors

Info

Publication number: ATE396992T1
Authority: AT; Austria
Prior art keywords: muscarin; antagonists; receptor; salts; quinuclidine derivative
Prior art date: 2005-03-08

Application number

AT05252102T

Other languages

English (en)

Inventor

Masahiko Hayakawa

Kiyohiro Samizu

Hiroshi Uebayashi

Ken Ikeda

Makoto Takeuchi

Original Assignee

Astellas Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-08

Filing date

2005-04-04

Publication date

2008-06-15

2005-04-04 Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc

2008-06-15 Application granted granted Critical

2008-06-15 Publication of ATE396992T1 publication Critical patent/ATE396992T1/de

Links

UQOFGTXDASPNLL-XHNCKOQMSA-N Muscarine Chemical compound C[C@@H]1O[C@H](C[N+](C)(C)C)C[C@H]1O UQOFGTXDASPNLL-XHNCKOQMSA-N 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
UANSQQFYKHHDJM-KRWDZBQOSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]naphthalene-1-carboxamide Chemical compound C1=CC=C2C(C(N[C@@H]3C4CCN(CC4)C3)=O)=CC=CC2=C1 UANSQQFYKHHDJM-KRWDZBQOSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/08—Mydriatics or cycloplegics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Ophthalmology & Optometry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Otolaryngology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT05252102T 2005-03-08 2005-04-04 Salze eines chinuclidin-derivats als antagonisten des muscarin-m3-rezeptors ATE396992T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2005063405		2005-03-08
JP2005088872A JP3701964B1 (ja)	2005-03-08	2005-03-25	キヌクリジン誘導体の新規な塩

Publications (1)

Publication Number	Publication Date
ATE396992T1 true ATE396992T1 (de)	2008-06-15

Family

ID=34940702

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05252102T ATE396992T1 (de)	2005-03-08	2005-04-04	Salze eines chinuclidin-derivats als antagonisten des muscarin-m3-rezeptors

Country Status (18)

Country	Link
US (1)	US7176219B2 (de)
EP (1)	EP1700858B1 (de)
JP (2)	JP3701964B1 (de)
KR (1)	KR20070110128A (de)
AR (1)	AR055741A1 (de)
AT (1)	ATE396992T1 (de)
AU (1)	AU2006221451A1 (de)
BR (1)	BRPI0608843A2 (de)
CA (1)	CA2599872A1 (de)
DE (1)	DE602005007176D1 (de)
ES (1)	ES2306030T3 (de)
IL (1)	IL185470A0 (de)
NO (1)	NO20075044L (de)
PL (1)	PL1700858T3 (de)
PT (1)	PT1700858E (de)
RU (1)	RU2007137064A (de)
TW (1)	TW200714599A (de)
WO (1)	WO2006095671A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20100137358A1 (en) *	1996-11-05	2010-06-03	Dr. Reddy's Laboratories Ltd.	Solifenacin compositions
CA2599158C (en) *	2005-02-25	2011-01-25	Astellas Pharma Inc.	Pharmaceutical agent comprising solifenacin
JP3701964B1 (ja)	2005-03-08	2005-10-05	アステラス製薬株式会社	キヌクリジン誘導体の新規な塩
CZ300692B6 (cs) *	2006-12-22	2009-07-15	Zentiva, A. S.	Zpusob prípravy solifenacinu
KR101653548B1 (ko) *	2008-01-08	2016-09-02	머크 샤프 앤드 돔 리미티드	2-｛4-［（3ｓ）-피페리딘-3-일］페닐｝-2ｈ-인다졸-7-카복스아미드의 약제학적으로 허용되는 염
PL3067353T3 (pl)	2008-07-29	2018-04-30	Krka, D.D., Novo Mesto	Sposób wytwarzania soli solifenacyny i ich włączenie do farmaceutycznych postaci dawkowania
US8278302B2 (en)	2009-04-08	2012-10-02	Boehringer Ingelheim International Gmbh	Substituted piperidines as CCR3 antagonists
UA109290C2 (uk)	2010-10-07	2015-08-10		Спільні кристали і солі інгібіторів ccr3
US10213421B2 (en)	2012-04-04	2019-02-26	Alkahest, Inc.	Pharmaceutical formulations comprising CCR3 antagonists
WO2014022139A1 (en) *	2012-07-31	2014-02-06	University Of Massachusetts Medical School	Methods for identifying agents for treating smooth muscle disorders and compositions thereof
JP2022504228A (ja)	2018-10-03	2022-01-13	テサロ，インコーポレイテッド	ニラパリブ遊離塩基の結晶形態

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO2005012I1 (no)	1994-12-28	2005-06-06	Debio Rech Pharma Sa	Triptorelin og farmasoytisk akseptable salter derav
GB9600063D0 (en)	1996-01-03	1996-03-06	Fujisawa Pharmaceutical Co	Guaridine derivatives
JPH107675A (ja)	1996-06-21	1998-01-13	Yamanouchi Pharmaceut Co Ltd	新規なイソキノリン誘導体又はその塩
JP2002104968A (ja)	2000-09-28	2002-04-10	Senju Pharmaceut Co Ltd	毛様体筋の緊張緩和剤
PT1405638E (pt) *	2001-07-10	2011-04-06	Astellas Pharma Inc	Composição farmacêutica compreendendo 1-fenil-1,2,3,4 tetrahidroisoquinolino- 2-carboxilato de quinuclidin-3'-ilo para tratamento de cistite intersticial e/ou prostatite não bacteriana
JP3701964B1 (ja)	2005-03-08	2005-10-05	アステラス製薬株式会社	キヌクリジン誘導体の新規な塩

2005
- 2005-03-25 JP JP2005088872A patent/JP3701964B1/ja not_active Expired - Lifetime
- 2005-04-04 ES ES05252102T patent/ES2306030T3/es not_active Expired - Lifetime
- 2005-04-04 EP EP05252102A patent/EP1700858B1/de not_active Expired - Lifetime
- 2005-04-04 DE DE602005007176T patent/DE602005007176D1/de not_active Expired - Fee Related
- 2005-04-04 AT AT05252102T patent/ATE396992T1/de not_active IP Right Cessation
- 2005-04-04 PL PL05252102T patent/PL1700858T3/pl unknown
- 2005-04-04 PT PT05252102T patent/PT1700858E/pt unknown
- 2005-05-13 US US11/128,238 patent/US7176219B2/en not_active Expired - Fee Related
2006
- 2006-02-22 TW TW095105953A patent/TW200714599A/zh unknown
- 2006-03-03 AR ARP060100801A patent/AR055741A1/es unknown
- 2006-03-06 RU RU2007137064/04A patent/RU2007137064A/ru not_active Application Discontinuation
- 2006-03-06 KR KR1020077022738A patent/KR20070110128A/ko not_active Withdrawn
- 2006-03-06 WO PCT/JP2006/304241 patent/WO2006095671A1/ja not_active Ceased
- 2006-03-06 CA CA002599872A patent/CA2599872A1/en not_active Abandoned
- 2006-03-06 JP JP2007507092A patent/JP4605218B2/ja not_active Expired - Fee Related
- 2006-03-06 AU AU2006221451A patent/AU2006221451A1/en not_active Abandoned
- 2006-03-06 BR BRPI0608843-0A patent/BRPI0608843A2/pt not_active Application Discontinuation
2007
- 2007-08-23 IL IL185470A patent/IL185470A0/en unknown
- 2007-10-05 NO NO20075044A patent/NO20075044L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2006095671A1 (ja)	2006-09-14
US7176219B2 (en)	2007-02-13
US20060205770A1 (en)	2006-09-14
EP1700858B1 (de)	2008-05-28
CA2599872A1 (en)	2006-09-14
DE602005007176D1 (de)	2008-07-10
JP4605218B2 (ja)	2011-01-05
JPWO2006095671A1 (ja)	2008-08-14
RU2007137064A (ru)	2009-04-20
JP2008308406A (ja)	2008-12-25
AR055741A1 (es)	2007-09-05
JP3701964B1 (ja)	2005-10-05
TW200714599A (en)	2007-04-16
AU2006221451A1 (en)	2006-09-14
NO20075044L (no)	2007-12-05
KR20070110128A (ko)	2007-11-15
IL185470A0 (en)	2008-01-06
PT1700858E (pt)	2008-07-17
ES2306030T3 (es)	2008-11-01
BRPI0608843A2 (pt)	2010-02-02
EP1700858A1 (de)	2006-09-13
PL1700858T3 (pl)	2008-10-31

Legal Events

Date

Code

Title

Description

2008-11-15

UEP

Publication of translation of european patent specification

Ref document number: 1700858

Country of ref document: EP

2011-01-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE509928T1 (de)	2011-06-15	8-azabicycloä3.2.1üoktan-verbindungen als mu- opioid-rezeptorantagonisten
ATE555111T1 (de)	2012-05-15	Chinuclidinol-derivate als muscarinrezeptor- antagonisten
ATE413874T1 (de)	2008-11-15	Neue thiophen-derivate als sphingosin-1-phosphat- 1-rezeptorantagonisten
ATE505467T1 (de)	2011-04-15	2-aza-bicycloä3.1.0ühexanderivate als orexin- rezeptorantagonisten
ATE523195T1 (de)	2011-09-15	Neue thiophen-derivate als sphingosin-1-phosphat- 1-rezeptorantagonisten
EP2049110A4 (de)	2011-08-10	Verbrückte diazepanorexin-rezeptorantagonisten
ATE537151T1 (de)	2011-12-15	Pyrazolinverbindungen als mineralocorticoidrezeptorantagonisten
BRPI0713826A2 (pt)	2015-05-12	Derivados dq quinuclidina como antagonistas dos receptores muscarinicos m3
DE602007009305D1 (de)	2010-10-28	Thiazolpyrazolopyrimidine als antagonisten des crf1-rezeptors
BRPI0815948A2 (pt)	2019-09-24	"compostos heterocíclicos como antagonistas de receptorncrth2"
BRPI0815797A2 (pt)	2015-06-16	Compostos 8-azabiciclo[3.2.1]octil-2-hidroxibanzamida como antagonistas de receptor opióide mu
ATE533744T1 (de)	2011-12-15	N-benzoypyrrolidin-3-ylamine als histamin-3 antagonisten
ATE537149T1 (de)	2011-12-15	Sulfonyl-pyrazolinyl-1-carboxamidinderivate als 5-ht6-antagonisten
ATE477243T1 (de)	2010-08-15	2-aminochinoline als 5-ht(5a)- rezeptorantagonisten
ATE421511T1 (de)	2009-02-15	Indol-3-carbonyl-spiro-piperidinderivate als antagonisten des v1a-rezeptors
BRPI0923237A2 (pt)	2019-09-24	compostos de 4-azetidinil-1-heteroaril-ciclohexanol antagonistas de ccr2
ATE495167T1 (de)	2011-01-15	Piperidin-4-yl-pyridazin-3-yl-aminderivate als schnell dissoziierende antagonisten des dopamin-2-rezeptors
DK1973886T3 (da)	2013-03-18	Prokineticin-1-receptor-antagonister
ATE547407T1 (de)	2012-03-15	Alkylthiopyrimidine als crth2-antagonisten
ZA201007988B (en)	2011-07-27	Quinuclidine derivatives as muscarinic m3 receptor antagonists
ATE396992T1 (de)	2008-06-15	Salze eines chinuclidin-derivats als antagonisten des muscarin-m3-rezeptors
EP2249833A4 (de)	2011-03-09	Prodrugs von cgrp-rezeptorantagonisten
ATE429428T1 (de)	2009-05-15	Indanderivate als antagonisten des mch-rezeptors
DK1928821T3 (da)	2009-03-16	Carboxamidderivater som muscarinreceptorantagonister
ATE537144T1 (de)	2011-12-15	Nitrierte heterocyclische verbindungen als endothelinrezeptorantagonisten